कोशिश गोल्ड - मुक्त

PCI asks Councils to issue certificates to passed-out D Pharm

Chronicle Pharmabiz

|

August 21, 2025

THE Pharmacy Council of India (PCI) has asked the State Pharmacy Councils to issue registration certificates to the diploma in pharmacy students who were admitted in 2022-23 and passed out, till the exit exam is conducted.

The Council, in its circular on August 7, said, "All State Pharmacy Councils are hereby requested to issue registered certificate to the passed-out students of 2022-23 admitted batch till the exit exam conducted as per the prescribed conditions u/s 32(2) of the Pharmacy Act, 1948."

According to the Section 32(2) of the Pharmacy Act, 1948, a person shall on payment of the prescribed fee be entitled to have his name entered on the register if he has attained the age of 18 years, if he resides, or carries on the business or profession of pharmacy, in the state and if he has passed an approved examination or possesses a qualification approved under Section 14 (or is a registered pharmacist of another state).

Chronicle Pharmabiz से और कहानियाँ

Chronicle Pharmabiz

Recent developments in Bangladesh pharma industry

Over the past four decades, the pharmaceutical industry in Bangladesh has undergone a sweeping transformation- emerging from its modest, import-dependent roots into a powerful, innovation-driven sector at the forefront of national development. What once relied heavily on foreign suppliers for basic medicines has now evolved into a self-reliant, technologically advanced industry capable of producing everything from lifesaving generics to complex oncology drugs.

time to read

7 mins

October 30, 2025

Chronicle Pharmabiz

Asia Labex showcases latest advancements in lab technology

DRIVEN by increased investment in pharmaceutical and biotech R&D, a rising need for advanced diagnostic equipment due to disease prevalence, and the growing adoption of automation in labs, the pharma laboratory equipment market has positive prospects.

time to read

6 mins

October 30, 2025

Chronicle Pharmabiz

AMMOI demands insurance for Ayurveda day care therapies

THE Ayurvedic Medicine Manufacturers Organ- isation of India (AM- MOI) has sought Union Ayush Minister Prataprao Jadhav's immediate interven- tion to ensure health insurance covers for Ayurvedic day care therapies.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

Global API market poised for significant changes

The global API market is poised for significant transformation in the coming decade, with growth concentrated in complex APIs, biologics, peptides, and high-potency APIS (HPAPIs).

time to read

6 mins

October 30, 2025

Chronicle Pharmabiz

PvPI identifies 16 India specific signals

THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been communicated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

CDSCO sets up digital system to monitor quality of solvents

THE Central Drugs Standard Control Organisation (CDSCO) has set up a Digital Monitoring System on the Online National Drugs Licensing System (ONDLS) portal to monitor the supply chain as well as quality of the high-risk solvents and has asked the State drug controllers to direct all manufacturers of pharma grade solvents to obtain manufacturing license through the portal.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

Surgicals import grows 11.58%, exports remain stagnant in August

IMPORTS of surgical equipment to the country have reported a decline of 11.58% even as the export of these products was almost stagnant during the month of August, 2025. For the first five months of the current fiscal, imports registered almost 9% growth compared to the same period a year ago.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

Chronicle Pharmabiz

API China focuses on innovation & global co-operation

In recent years, the scale of China's pharmaceutical active pharmaceutical ingredients (APIs) and its global market share have gradually increased. The China API market is experiencing significant growth, driven by expanding global pharmaceutical demand, an aging population, rising chronic disease rates, and the expiration of patents boosting demand for generics.

time to read

6 mins

October 30, 2025

Chronicle Pharmabiz

PVPI identifies 16 India specific signals

THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been com- municated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

PM&AC 2025 redefines excellence in pharma manufacturing

THE 7th Annual Pharma Manufacturing & Automation Convention (PM&AC) 2025, co-located with the Pharma Manufacturing & Automation Excellence Awards, concluded on October 8 and 9 at Novotel HICC, Hyderabad, with resounding success.

time to read

3 mins

October 30, 2025

Listen

Translate

Share

-
+

Change font size